Life Sciences

Distal Solutions, a medical device company, has been acquired by Resonetics, based in Nashua, New Hampshire.

Framingham-based Clinical Enterprise, Inc., doing business as empowerDX, announced on Monday its at-home COVID-19 testing kit received emergency use authorization from the U.S. Food & Drug Administration for children three years and older.

Holliston biotechnology company Biostage Inc. reported it has $500,000 in operating cash on hand, enough to carry it into the third quarter.

As Worcester grows, so does its appeal to investors and developers.

Audio equipment manufacturer Bose, headquartered in Framingham, has announced new direct-to-consumer hearing aids that use an app to allow users to skip a doctor visit, hearing test or prescription.

Marlborough medical device manufacturer Hologic has announced a $20-million commitment to Project Health Equality, a new initiative aimed at addressing health inequities for Black and Hispanic women.

Holliston biotechnology firm Harvard Bioscience continued its fourth quarter momentum with revenue up 14% in the first quarter of 2021 when compared to the first quarter of 2020.

GE Healthcare's U.S. pharmaceutical diagnostics team, which has its headquarters in Marlborough, announced Thursday it will add 70 employees at the Marlborough office.

Framingham biosurgical device manufacturer Arch Therapeutics, Inc., has named Michael Abrams its new chief financial officer.

Boston Scientific reported a first quarter turnaround with profits rising from $11 million in the quarter in 2020 to $327 million this year.